Article

CHK2 immunohistochemical expression in prostatic carcinoma of Egyptian patients

2024-10-15

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: Prostatic carcinoma (PCa) is a diverse disease with a complex molecular landscape that evolves throughout disease progression. There is a great need for novel biomarkers that are more effective at predicting PCa outcomes. CHK2 is a tumor suppressor gene and is considered a prospective target for prognostic and therapeutic applications. This study aims to investi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3eaacdc5-3fa0-554b-b8ed-9ad46aae8f5e
DOI: 10.21203/rs.3.rs-4918576/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

CHK2 immunohistochemical expression in prostatic carcinoma of Egyptian patientsDOI 10.21203/rs.3.rs-4918576/v1Read

Prostatic cancers: understanding their molecular pathology and the 2016 WHO classificationSemantic proximity Read

Expression and role of CNIH2 in prostate cancerSemantic proximity Read

Altered staining patterns and expression level of Engrailed-2 in Benign prostatic hyperplasia and Prostate Cancer predict Prostatic disease progressionSemantic proximity Read

Transcriptional analysis reveals a markedly reduced expression of the voltage-dependent calcium channel α2δ1 subunit in canine prostate cancer compared to benign prostatic hyperplasiaSemantic proximity Read

HIST1H2BN induced cell proliferation and EMT phenotype in prostate cancer via NF-κB signal pathway.Semantic proximity Read

Identification and functional activity of Nik related kinase (NRK) in benign hyperplastic prostateSemantic proximity Read

Over-expression of YTHDC2 Contributes to Progression of Prostate Cancer and Predicts Poor Outcome in Patients with Prostate CancerSemantic proximity Read

Determination of ERG(+), EZH2, NKX3.1, and SPINK-1 Subtypes to Evaluate Their Association With Clonal Origin and Disease Progression in Multifocal Prostate CancerSemantic proximity Read

Molecular Characterization of Prostate Cancer in Middle Eastern Population Highlights Differences with Western Populations with Prognostic ImplicationSemantic proximity Read

Associations of CYLD, JAK2 and TLR4 Genotypes with PSA Levels and Immunophenotype in Benign Prostatic Hyperplasia and Prostate Cancer.Semantic proximity Read

RCC2 promotes prostate cancer cell proliferation and migration through Hh/GLI1 signaling pathway and cancer stem-like cellsSemantic proximity Read

Evaluation of NUF2 and GMNN Expression in Prostate Cancer: Potential Biomarkers for Prostate Cancer ScreeningSemantic proximity Read